Results 251 to 260 of about 226,776 (323)

The Long Island Lighting Company Productivity Incentive Program for Tree Trimming

, 1979
Thomas David
openalex   +2 more sources

Increasing Participation and Completion Rates in Questionnaire Surveys of Primary Care Patients: Cluster-Randomized Study.

Interact J Med Res
Sebo P, Tudrej B, Bernard A, Delaunay B, Dupuy A, Malavergne C, Maisonneuve H.   +6 more
europepmc   +1 more source

Effect of the mixed ownership reform on the stock market: Evidence from China. [PDF]

PLoS One
Gu X, Qiao S, Wang Y, Song T.
europepmc   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Effects of motivational incentives on GATB "F" and "M" subtest performance with hospitalized neuropsychiatric patients

, 1970
Richard Wayne Myers
openalex   +1 more source

Increasing financial incentives can lower the cost of trial recruitment. [PDF]

Trials
Schwartz A, Weiner SJ, Harrod M.
europepmc   +1 more source

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

Molecular Oncology, EarlyView.
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani, Gilgi Friedlander, Gili Perry, Nora Balint‐Lahat, Shlomit Gilad, Dana Morzaev‐Sulzbach, Anjana Shenoy, Noa Bossel Ben‐Moshe, Anya Pavlovsky, Rinat Bernstein‐Molho, Eytan Domany, Iris Barshack, Tamar Geiger, Bella Kaufman, Einav Nili Gal‐Yam   +14 more
wiley   +1 more source

Outcomes of Incentive Spirometry for Patients Undergoing Coronary Artery Bypass Surgery: A Randomised Controlled Trial. [PDF]

Int J Nurs Pract
Gökçe E, Alptekin D, Gezer D, Akpolat R, Şişman H, Kayhanlı G, Arslan S.   +6 more
europepmc   +1 more source

Ubiquitination of transcription factors in cancer: unveiling therapeutic potential

Molecular Oncology, EarlyView.
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley   +1 more source

Incentives for teaching

Academic Medicine, 1996
B A Bennett, J D Hoban, S A Vanderweide, M E Harrington, J M Ernest, L Cariaga-Lo   +5 more
openaire   +4 more sources